Real-world assessment of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) nasopharyngeal swab testing in a region with a high burden of coronavirus disease 2019 (COVID-19).

Rohit B SangalDavid R PeaperCraig RothenbergHasan FadlallahMotunrayo Mobolaji-LawalMarie L LandryL Scott SussmanAndrew UlrichArjun K Venkatesh

Published in: Infection control and hospital epidemiology (2021)

Concerns persist regarding possible false-negative results that may compromise COVID-19 containment. Although obtaining a true false-negative rate is infeasible, using real-life observations, the data suggest a possible false-negative rate of ˜2.3%. Use of a sensitive, amplified RNA platform should reassure healthcare systems.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
healthcare
electronic health record
big data
risk factors
artificial intelligence